NorthX Biologics AB is a 7,000 square meter GMP facility in Matfors, Sweden. At NorthX Biologics we take pride in providing services from early development to commercialisation of biopharmaceuticals. Our main but not exclusive focus is to provide support to cell and gene therapy projects and products.
We specialise in:
Process development
Large Scale DNA
pDNA
HQ DNA
Microbial production
Formulation
QC, QA, QP
We specialise in:
Process development
Large Scale DNA
pDNA
HQ DNA
Microbial production
Formulation
QC, QA, QP
Location: Sweden, Tuna District
Employees: 51-200
Investors 2
| Date | Name | Website |
| 08.09.2022 | Flerie Inv... | flerie.com |
| 20.05.2025 | Signet Hea... | signetheal... |
Mentions in press and media 4
| Date | Title | Description |
| 23.01.2026 | Diamyd Medical deepens long-term manufacturing collaboration for retogatein | Diamyd Medical deepens long-term manufacturing collaboration for retogatein Fri, Jan 23, 2026 08:45 CET Report this content Diamyd Medical is taking the next step in a long-term manufacturing collaboration with APL and, in parallel, is init... |
| 01.12.2025 | NorthX Biologics achieves milestone GMP certification to manufacture vididencel – Mendus’ lead cell therapy product for acute and chronic myeloid leukemias | NorthX Biologics achieves milestone GMP certification to manufacture vididencel – Mendus’ lead cell therapy product for acute and chronic myeloid leukemias Mon, Dec 01, 2025 08:30 CET Report this content Off-the-shelf cellular immunotherapy... |
| 22.05.2025 | NorthX Biologics Receives Growth Investment from Signet Healthcare Partners | NorthX Biologics, a Stockholm, Sweden-based biopharmaceutical contract, development and manufacturing organization (CDMO), received a growth investment from Signet Healthcare Partners. The amount of the deal was not disclosed. Following the... |
| 04.11.2024 | Neogap Therapeutics partners with NorthX Biologics to advance scalable manufacturing for its novel cancer cell therapy | Neogap Therapeutics partners with NorthX Biologics to advance scalable manufacturing for its novel cancer cell therapy Mon, Nov 04, 2024 06:30 CET Report this content Neogap Therapeutics, a Swedish clinical-stage biotechnology company, has ... |